✦ LIBER ✦

Incidence and risk of treatment-related mortality in cancer patients treated with EGFR-TKIs: A meta-analysis of 22 phase III randomized controlled trials

✍ Scribed by Qi, Wei-Xiang; Tang, Li-Na; He, Ai-Na; Yao, Yang; Shen, Zan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of high-grade bleeding in patients

✍ Xiao Feng Hang; Wen Sheng Xu; Jun Xue Wang; Lei Wang; Hai Guang Xin; Rui Qi Zhan 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 743 KB

Incidence and risk of rash to mTOR inhib

✍ Shameem, Raji; Lacouture, Mario; Wu, Shenhong 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 470 KB

KRAS mutations and resistance to EGFR-TK

✍ Mao, Chen; Qiu, Li-Xin; Liao, Ru-Yan; Du, Fang-Bing; Ding, Hong; Yang, Wan-Chun; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 171 KB

A meta-analysis of two Irinotecan-based

✍ Vamvakas, L.; Karampeazis, A.; Boukovinas, I.; Kakolyris, S.; Polyzos, A.; Ninto 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 46 KB

Incidence, risk factors, and outcomes of

✍ Saad, F.; Brown, J. E.; Van Poznak, C.; Ibrahim, T.; Stemmer, S. M.; Stopeck, A. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 197 KB

PRS3 Inhaled Anticholinergics and Risk o

✍ M.R. Ajmera; P.B. Rane; G. Kelley; U. Sambamoorthi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB